Skip to content

Abnormalities in functions of thyroid gland in COVID-19 patients

Thyroid Dysfunction In Patients Of COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035092
Enrollment
50
Registered
2021-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed COVID-19 cases (Positive for SARS-CoV-2 by RT-PCR or Rapid Antigen Test)

Exclusion criteria

Exclusion criteria: 1. Patients who are diagnosed with hyperthyroidism or hypothyroidism and currently on treatment for the same 2. Patients with past history of thyroid disorder or have received treatment for the same 3. Patients with history of thyroid cancer or surgery 4. Patients receiving drugs affecting thyroid function like amiodarone, lithium, etc. 5. Patients who have received cancer chemotherapy or radiotherapy in the last 6 months 6. Patients who have recently received iodinated contrast media.

Design outcomes

Primary

MeasureTime frame
Proportion of COVID-19 patients having various thyroid abnormalities viz. hypothyroidism, thyrotoxicosis, Gravesâ?? disease, Hashimotoâ??s thyroiditis, sub-acute thyroiditis and sick euthyroid syndrome during admissionTimepoint: At the end of the study

Secondary

MeasureTime frame
Compare the two groups of patients i.e., those with thyroid abnormalities and those without thyroid abnormalities, for significant differences in their clinical severity and/or serum inflammatory markersTimepoint: At the end of the study;Correlation of thyroid function abnormalities with clinical severity of COVID-19Timepoint: At the end of the study;Correlation of thyroid function abnormalities with serum inflammatory markers viz. CRP, Ferritin, LDH, and IL-6Timepoint: At the end of the study

Countries

India

Contacts

Public ContactDr Ban Anuj Achyut

Maulana Azad Medical College, New Delhi

sumeetsingla555@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026